Search
Regeneron Pharmaceuticals Inc
REGNAdd to Watchlist
827.720USD
-15.750-1.87%
Close 09-04 16:00（ET）
85.57BMarket Cap
19.48P/E TTM
Regeneron Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-09-04The current valuation score of Regeneron Pharmaceuticals Inc is 9.57, ranking 19 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is 19.48, which is 53.02% below the recent high of 29.82 and 40.65% above the recent low of 11.56.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.